scispace - formally typeset
L

Ling Li

Researcher at City of Hope National Medical Center

Publications -  73
Citations -  3729

Ling Li is an academic researcher from City of Hope National Medical Center. The author has contributed to research in topics: Leukemia & Stem cell. The author has an hindex of 28, co-authored 60 publications receiving 2818 citations. Previous affiliations of Ling Li include Beckman Research Institute & Zhejiang University.

Papers
More filters
Journal ArticleDOI

Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib

TL;DR: It is shown that the NAD(+)-dependent deacetylase SIRT1 is overexpressed in human CML LSC and Activation of p53 via Sirt1 inhibition represents a potential approach to target C ML LSC.
Journal ArticleDOI

Shikonin circumvents cancer drug resistance by induction of a necroptotic death.

TL;DR: Shikonin, a naturally occurring naphthoquinone, induced a cell death in MCF-7 and HEK293 distinct from apoptosis and characterized with (a) a morphology of necrotic cell death, (b) loss of plasma membrane integrity, loss of mitochondrial membrane potentials, activation of autophagy, but not a contributing factor; (e) elevation of reactive oxygen species with no critical roles contributing to cell death; and (f) the cell death was prevented by a small molecule, necrostatin-1, that specifically
Journal ArticleDOI

Stem cell quiescence.

TL;DR: Current advances in understanding normal stem cell quiescence, their significance for CSC quiescent and drug resistance, and the potential clinical applications are reviewed.